Logo image of AGTI

AGILITI INC (AGTI) Stock Fundamental Analysis

NYSE:AGTI - US00848J1043 - Common Stock

10.05 USD
-0.05 (-0.5%)
Last: 5/6/2024, 8:04:00 PM
10.05 USD
0 (0%)
After Hours: 5/6/2024, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AGTI. AGTI was compared to 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of AGTI while its profitability can be described as average. AGTI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AGTI had positive earnings in the past year.
In the past year AGTI had a positive cash flow from operations.
In multiple years AGTI reported negative net income over the last 5 years.
In the past 5 years AGTI always reported a positive cash flow from operatings.
AGTI Yearly Net Income VS EBIT VS OCF VS FCFAGTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -0.81%, AGTI perfoms like the industry average, outperforming 52.99% of the companies in the same industry.
AGTI has a Return On Equity (-2.06%) which is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.32%, AGTI perfoms like the industry average, outperforming 50.43% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AGTI is significantly below the industry average of 9.19%.
Industry RankSector Rank
ROA -0.81%
ROE -2.06%
ROIC 2.32%
ROA(3y)0.46%
ROA(5y)-0.4%
ROE(3y)1.27%
ROE(5y)-1.8%
ROIC(3y)3.04%
ROIC(5y)N/A
AGTI Yearly ROA, ROE, ROICAGTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

AGTI has a Operating Margin of 5.51%. This is in the better half of the industry: AGTI outperforms 66.67% of its industry peers.
In the last couple of years the Operating Margin of AGTI has declined.
The Gross Margin of AGTI (34.41%) is better than 62.39% of its industry peers.
AGTI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.51%
PM (TTM) N/A
GM 34.41%
OM growth 3Y5.72%
OM growth 5Y-12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.42%
GM growth 5Y-0.3%
AGTI Yearly Profit, Operating, Gross MarginsAGTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

2

2. Health

2.1 Basic Checks

AGTI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AGTI has more shares outstanding
Compared to 5 years ago, AGTI has more shares outstanding
AGTI has a worse debt/assets ratio than last year.
AGTI Yearly Shares OutstandingAGTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
AGTI Yearly Total Debt VS Total AssetsAGTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that AGTI is in the distress zone and has some risk of bankruptcy.
AGTI's Altman-Z score of 1.19 is in line compared to the rest of the industry. AGTI outperforms 44.44% of its industry peers.
AGTI has a debt to FCF ratio of 12.95. This is a negative value and a sign of low solvency as AGTI would need 12.95 years to pay back of all of its debts.
AGTI has a Debt to FCF ratio of 12.95. This is comparable to the rest of the industry: AGTI outperforms 57.27% of its industry peers.
AGTI has a Debt/Equity ratio of 1.13. This is a high value indicating a heavy dependency on external financing.
AGTI has a Debt to Equity ratio of 1.13. This is in the lower half of the industry: AGTI underperforms 63.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 12.95
Altman-Z 1.19
ROIC/WACC0.32
WACC7.29%
AGTI Yearly LT Debt VS Equity VS FCFAGTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

AGTI has a Current Ratio of 1.72. This is a normal value and indicates that AGTI is financially healthy and should not expect problems in meeting its short term obligations.
AGTI has a Current ratio of 1.72. This is in the better half of the industry: AGTI outperforms 64.96% of its industry peers.
AGTI has a Quick Ratio of 1.34. This is a normal value and indicates that AGTI is financially healthy and should not expect problems in meeting its short term obligations.
AGTI has a Quick ratio of 1.34. This is comparable to the rest of the industry: AGTI outperforms 52.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.34
AGTI Yearly Current Assets VS Current LiabilitesAGTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

3

3. Growth

3.1 Past

AGTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -34.12%.
Looking at the last year, AGTI shows a small growth in Revenue. The Revenue has grown by 4.75% in the last year.
AGTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.75% yearly.
EPS 1Y (TTM)-34.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)4.75%
Revenue growth 3Y14.95%
Revenue growth 5Y15.75%
Sales Q2Q%0.95%

3.2 Future

Based on estimates for the next years, AGTI will show a small growth in Earnings Per Share. The EPS will grow by 4.80% on average per year.
AGTI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.53% yearly.
EPS Next Y8.01%
EPS Next 2Y7.33%
EPS Next 3Y4.8%
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y4.69%
Revenue Next 3Y5.53%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AGTI Yearly Revenue VS EstimatesAGTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B
AGTI Yearly EPS VS EstimatesAGTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.95, the valuation of AGTI can be described as rather expensive.
76.07% of the companies in the same industry are more expensive than AGTI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.07. AGTI is valued slightly cheaper when compared to this.
AGTI is valuated correctly with a Price/Forward Earnings ratio of 15.58.
Based on the Price/Forward Earnings ratio, AGTI is valued a bit cheaper than 74.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.59, AGTI is valued a bit cheaper.
Industry RankSector Rank
PE 17.95
Fwd PE 15.58
AGTI Price Earnings VS Forward Price EarningsAGTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AGTI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AGTI is cheaper than 78.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AGTI is valued cheaply inside the industry as 82.91% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.39
EV/EBITDA 10.17
AGTI Per share dataAGTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.24
PEG (5Y)N/A
EPS Next 2Y7.33%
EPS Next 3Y4.8%

0

5. Dividend

5.1 Amount

AGTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGILITI INC

NYSE:AGTI (5/6/2024, 8:04:00 PM)

After market: 10.05 0 (0%)

10.05

-0.05 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-07 2024-05-07/amc
Earnings (Next)08-06 2024-08-06/amc
Inst Owners4.59%
Inst Owner Change0%
Ins Owners0.26%
Ins Owner Change0%
Market Cap1.37B
Analysts51.67
Price Target10.2 (1.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.61%
Min EPS beat(2)-2.18%
Max EPS beat(2)7.4%
EPS beat(4)2
Avg EPS beat(4)5.03%
Min EPS beat(4)-7.15%
Max EPS beat(4)22.04%
EPS beat(8)5
Avg EPS beat(8)9.4%
EPS beat(12)9
Avg EPS beat(12)51.52%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)1.94%
Revenue beat(4)3
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)1.94%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)8
Avg Revenue beat(12)0.53%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.05%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)1.35%
EPS NY rev (1m)0%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 17.95
Fwd PE 15.58
P/S 1.16
P/FCF 16.39
P/OCF 8.05
P/B 1.45
P/tB N/A
EV/EBITDA 10.17
EPS(TTM)0.56
EY5.57%
EPS(NY)0.65
Fwd EY6.42%
FCF(TTM)0.61
FCFY6.1%
OCF(TTM)1.25
OCFY12.43%
SpS8.64
BVpS6.92
TBVpS-5.36
PEG (NY)2.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.81%
ROE -2.06%
ROCE 2.94%
ROIC 2.32%
ROICexc 2.34%
ROICexgc 9.97%
OM 5.51%
PM (TTM) N/A
GM 34.41%
FCFM 7.1%
ROA(3y)0.46%
ROA(5y)-0.4%
ROE(3y)1.27%
ROE(5y)-1.8%
ROIC(3y)3.04%
ROIC(5y)N/A
ROICexc(3y)3.09%
ROICexc(5y)N/A
ROICexgc(3y)14.42%
ROICexgc(5y)N/A
ROCE(3y)3.85%
ROCE(5y)N/A
ROICexcg growth 3Y3.65%
ROICexcg growth 5Y-11.31%
ROICexc growth 3Y8.13%
ROICexc growth 5Y-21.08%
OM growth 3Y5.72%
OM growth 5Y-12.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.42%
GM growth 5Y-0.3%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.13
Debt/FCF 12.95
Debt/EBITDA 4.45
Cap/Depr 49.7%
Cap/Sales 7.36%
Interest Coverage 1.06
Cash Conversion 71.16%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.34
Altman-Z 1.19
F-Score5
WACC7.29%
ROIC/WACC0.32
Cap/Depr(3y)44.33%
Cap/Depr(5y)40.21%
Cap/Sales(3y)7.19%
Cap/Sales(5y)7.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y8.01%
EPS Next 2Y7.33%
EPS Next 3Y4.8%
EPS Next 5YN/A
Revenue 1Y (TTM)4.75%
Revenue growth 3Y14.95%
Revenue growth 5Y15.75%
Sales Q2Q%0.95%
Revenue Next Year4.09%
Revenue Next 2Y4.69%
Revenue Next 3Y5.53%
Revenue Next 5YN/A
EBIT growth 1Y-29.58%
EBIT growth 3Y21.53%
EBIT growth 5Y1.48%
EBIT Next Year245.12%
EBIT Next 3Y57.21%
EBIT Next 5YN/A
FCF growth 1Y-25.75%
FCF growth 3Y2.73%
FCF growth 5Y21.03%
OCF growth 1Y-15.01%
OCF growth 3Y7.63%
OCF growth 5Y14.5%